A Randomized Phase II Trial of Fludarabine/Melphalan 100 versus Fludarabine/Melphalan 140 followed by Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Multiple Myeloma

BACKGROUND: Allogeneic hematopoietic stem cell transplantation (allo-HCT) is a potentially curative treatment for multiple myeloma (MM); however, due to high-treatment related mortality (TRM) its role is not well defined. METHODS: Patients with newly diagnosed, relapsed, or primary refractory myelom...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Bashir, Qaiser, Khan, Hassan, Thall, Peter F, Liu, Ping, Shah, Nina, Kebriaei, Partow, Parmar, Simrit, Oran, Betul, Ciurea, Stefan, Nieto, Yago, Jones, Roy, Hosing, Chitra M, Popat, Uday R, Dinh, Yvonne T, Rondon, Gabriela, Orlowski, Robert Z., Shah, Jatin J, De Lima, Marcos, Shpall, Elizabeth, Champlin, Richard, Giralt, Sergio, Qazilbash, Muzaffar
格式: Artigo
語言:Inglês
出版: 2013
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4157818/
https://ncbi.nlm.nih.gov/pubmed/23872222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2013.07.008
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍